Serum markers of bone formation in parenteral nutrition patients

[1]  D. Jelliffe,et al.  The assessment of the nutritional status of the community. , 1997 .

[2]  A. Parfitt.  Serum markers of bone formation in parenteral nutrition patients , 1991, Calcified Tissue International.

[3]  R. Busuttil,et al.  Absence of hyperparathyroidism in severe liver disease , 1989, Calcified Tissue International.

[4]  S. Ott,et al.  D-lactate and metabolic bone disease in patients receiving long-term parenteral nutrition. , 1989, JPEN. Journal of parenteral and enteral nutrition.

[5]  S. Ott,et al.  Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. , 1988, The American journal of clinical nutrition.

[6]  S. Ott,et al.  Mineral loss in the parenteral nutrition patient. , 1988, The American journal of clinical nutrition.

[7]  J. Pødenphant,et al.  Bone turnover in spinal osteoporosis , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  S. Ott,et al.  Heterogeneity of bone histology in parenteral nutrition patients. , 1987, The American journal of clinical nutrition.

[10]  J. Stepan,et al.  Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism. , 1987, The Journal of clinical endocrinology and metabolism.

[11]  J. Kopp,et al.  Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. , 1986, The Journal of clinical endocrinology and metabolism.

[12]  P. Delmas,et al.  Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. , 1986, The Journal of clinical endocrinology and metabolism.

[13]  M. Holick,et al.  Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. , 1986, The American journal of clinical nutrition.

[14]  D. Baylink,et al.  Skeletal alkaline phosphatase activity as a bone formation index in vitro. , 1986, Metabolism: clinical and experimental.

[15]  P. Delmas,et al.  Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. , 1986, The Journal of clinical investigation.

[16]  C. Christiansen,et al.  UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS , 1985, The Lancet.

[17]  R. Nissenson,et al.  Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis. , 1985, The Journal of clinical endocrinology and metabolism.

[18]  D. Cole,et al.  Serum osteocalcin concentrations in children with metabolic bone disease. , 1985, The Journal of pediatrics.

[19]  E. Orwoll,et al.  Hypochlorite radioiodination of parathyroid peptides (hPTH1-34, [Tyr43]hPTH44-68). , 1985, The Journal of laboratory and clinical medicine.

[20]  M. Deitel,et al.  Metabolic bone disease in a patient on long-term total parenteral nutrition: a case report with review of literature. , 1984, JPEN. Journal of parenteral and enteral nutrition.

[21]  J. Auwerx,et al.  Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. , 1984, The Journal of clinical endocrinology and metabolism.

[22]  P. Delmas,et al.  SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS , 1984, The Lancet.

[23]  K. Mann,et al.  Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. , 1983, The Journal of laboratory and clinical medicine.

[24]  S. Ott,et al.  Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. , 1983, Annals of internal medicine.

[25]  L. Deftos,et al.  Changes in plasma bone GLA protein during treatment of bone disease , 1982, Calcified Tissue International.

[26]  J. Harrison,et al.  A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease. , 1981, Annals of internal medicine.

[27]  A. Norman,et al.  Reduced Serum Levels of Iα, 25-Dihydroxyvitamin D During Long-term Total Parenteral Nutrition , 1981 .

[28]  A. Norman,et al.  BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITION , 1980, The Lancet.

[29]  L. Deftos,et al.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.

[30]  J. Harrison,et al.  Metabolic bone disease in patients receiving long-term total parenteral nutrition. , 1980, Annals of internal medicine.

[31]  M. Ament,et al.  Home parenteral nutrition in children with Crohn's disease: an effective management alternative. , 1979, Gastroenterology.

[32]  D. McGill,et al.  Home parenteral nutrition as primary therapy in patients with extensive Crohn's disease of the small bowel and malnutrition. , 1977, Gastroenterology.

[33]  G. Ellis,et al.  Sequential-saturation-type assay for serum 25-hydroxyvitamin D. , 1977, Clinical chemistry.

[34]  J. Winberg,et al.  Does breast milk protect against septicaemia in the newborn? , 1971, Lancet.

[35]  W. Peh.  Renal osteodystrophy. , 2002, American journal of orthopedics.

[36]  R. Eckstein,et al.  Hepatic osteodystrophy: Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease , 1989 .

[37]  M. de Vernejoul,et al.  Multifactorial low remodeling bone disease during cyclic total parenteral nutrition. , 1985, The Journal of clinical endocrinology and metabolism.

[38]  A. Alfrey.  Aluminum intoxication. , 1984, The New England journal of medicine.

[39]  R. Horst,et al.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. , 1984, The Journal of clinical endocrinology and metabolism.

[40]  A. Alfrey,et al.  Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption analysis of a chelate. , 1976, Clinical chemistry.